ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.7919
0.00%
Brent Oil
80.005
0.00%
Bitcoin
104,461.64
0.32%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Solventum Corporation (SOLV)

  7. Solventum Corporation (SOLV) Noticias

SOLV

Solventum (SOLV)

Solventum Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:SOLV
FechaHoraFuenteTítuloSímboloCompañía
08/01/202512:01GlobeNewswire Inc.Trian Issues Open Letter to Solventum ShareholdersNYSE:SOLVSolventum Corporation
08/01/202505:30PR Newswire (US)The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes Cures Through Impact InvestingNYSE:SOLVSolventum Corporation
17/12/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:SOLVSolventum Corporation
11/12/202415:56Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:SOLVSolventum Corporation
10/12/202416:26Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:SOLVSolventum Corporation
03/12/202416:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:SOLVSolventum Corporation
02/12/202415:58Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:SOLVSolventum Corporation
19/11/202405:50PR Newswire (US)Solventum to Participate in the Piper Sandler Healthcare ConferenceNYSE:SOLVSolventum Corporation
15/11/202415:13Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNYSE:SOLVSolventum Corporation
14/11/202408:00PR Newswire (US)Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner TreatmentNYSE:SOLVSolventum Corporation
08/11/202415:06Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NYSE:SOLVSolventum Corporation
08/11/202414:57Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:SOLVSolventum Corporation
07/11/202415:14Edgar (US Regulatory)Form 8-K - Current reportNYSE:SOLVSolventum Corporation
07/11/202415:05PR Newswire (US)Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year GuidanceNYSE:SOLVSolventum Corporation
24/10/202413:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNYSE:SOLVSolventum Corporation
15/10/202405:50PR Newswire (US)Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024NYSE:SOLVSolventum Corporation
14/10/202406:00PR Newswire (US)Solventum Announces Commitment to 100% Renewable Electricity by 2030NYSE:SOLVSolventum Corporation
10/10/202408:00PR Newswire (US)Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical OfficerNYSE:SOLVSolventum Corporation
10/09/202405:45PR Newswire (US)Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® TherapyNYSE:SOLVSolventum Corporation
28/08/202405:50PR Newswire (US)Solventum to Participate in Upcoming Investor ConferencesNYSE:SOLVSolventum Corporation
20/08/202408:00PR Newswire (US)Solventum autonomous coding listed in Epic ToolboxNYSE:SOLVSolventum Corporation
08/08/202415:05PR Newswire (US)Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year GuidanceNYSE:SOLVSolventum Corporation
23/07/202405:00IH Market NewsJohnson Controls Division Sold for $8 Billion; Alphabet’s Offer Rejected by Wiz; AMD President Announces RetirementNYSE:SOLVSolventum Corporation
16/07/202405:50PR Newswire (US)Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024NYSE:SOLVSolventum Corporation
02/07/202408:00PR Newswire (US)U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals RankingsNYSE:SOLVSolventum Corporation
24/06/202408:00PR Newswire (US)Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenueNYSE:SOLVSolventum Corporation
07/06/202405:55PR Newswire (US)Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"NYSE:SOLVSolventum Corporation
09/05/202405:50PR Newswire (US)Solventum Reports First Quarter 2024 Financial Results and Capital Allocation UpdateNYSE:SOLVSolventum Corporation
23/04/202415:45PR Newswire (US)Solventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor EventsNYSE:SOLVSolventum Corporation
15/04/202405:30PR Newswire (US)Solventum Names Shirley Edwards to Board of DirectorsNYSE:SOLVSolventum Corporation
 Showing the most relevant articles for your search:NYSE:SOLV

Su Consulta Reciente

BOV
GOGL34
Alphabet
BOV
AMGN34Q
AMGEN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados